• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜中央动脉阻塞急性期治疗:溶栓、高压氧治疗还是两者联合?

Acute phase treatment in central retinal artery occlusion: thrombolysis, hyperbaric oxygen therapy or both?

机构信息

Department of Neurology, Centro Hospitalar Universitário de São João, EPE, Porto, Portugal.

Department of Clinic Neurosciences and Mental Health, Medical Faculty of Porto University, Porto, Portugal.

出版信息

J Thromb Thrombolysis. 2020 Nov;50(4):984-988. doi: 10.1007/s11239-020-02072-0.

DOI:10.1007/s11239-020-02072-0
PMID:32166539
Abstract

Central retinal artery occlusion (CRAO) is a neuro-ophthalmological emergency. There is a finite time window for acute interventions such as revascularization (e.g. intravenous thrombolysis-IVT) and retinal oxygenation (e.g. hyperbaric oxygen therapy-HBOT) therapies. Case 1: A 35-year-old female presented with CRAO in the right eye (OD) confirmed by fluorescein angiography (FA) and optical coherence tomography (OCT). She underwent 4 sessions of HBOT (100% O2 at 2.4 atmosphere absolute for 90 min). Afterwards, visual defect on the nasal field was kept but visual acuity (VA) improved from counting fingers to 1.0. Case 2: A 65-year-old male presented with CRAO in his left eye (OS) with 1.5 h of evolution. Orbital sonography and OCT confirmed the presence of an embolus and he underwent IVT with rTPA (0.9 mg/kg). VA improved from light perception to 0.1. Case 3: A 21-year-old male presented acute visual loss in his OD with 2.5 h of evolution. OCT and retinography identified CRAO. He was submitted to IVT (rTPA-0.9 mg/kg) followed by 12 sessions of HBOT. VA improved from hand motion to 1.0. Our case series depicts the approaches and possible outcomes in acute management of an infrequent, but highly morbid, cerebroretinovascular disorder. Future clinical trials are warranted to tackle current difficulties in CRAO treatment.

摘要

视网膜中央动脉阻塞(CRAO)是一种神经眼科急症。急性干预(如血管再通治疗[例如,静脉内溶栓治疗-IVT]和视网膜氧合治疗[例如,高压氧治疗-HBOT])有一个有限的时间窗。

病例 1:一名 35 岁女性因右眼 CRAO 就诊,经荧光素血管造影(FA)和光学相干断层扫描(OCT)确诊。她接受了 4 次 HBOT(2.4 个绝对大气压下 100%氧气,每次 90 分钟)。此后,鼻侧视野的视觉缺陷仍存在,但视力(VA)从指数提高到 1.0。

病例 2:一名 65 岁男性因左眼 CRAO 就诊,发病时间为 1.5 小时。眼眶超声和 OCT 证实存在栓子,他接受了 rTPA(0.9mg/kg)的 IVT。VA 从光感提高到 0.1。

病例 3:一名 21 岁男性因右眼急性视力丧失就诊,发病时间为 2.5 小时。OCT 和视网膜摄影术确定了 CRAO。他接受了 IVT(rTPA-0.9mg/kg),随后进行了 12 次 HBOT。VA 从手动提高到 1.0。

本病例系列描述了急性处理罕见但高度病态的脑视网膜血管疾病的方法和可能的结果。需要进行未来的临床试验来解决 CRAO 治疗中的当前困难。

相似文献

1
Acute phase treatment in central retinal artery occlusion: thrombolysis, hyperbaric oxygen therapy or both?视网膜中央动脉阻塞急性期治疗:溶栓、高压氧治疗还是两者联合?
J Thromb Thrombolysis. 2020 Nov;50(4):984-988. doi: 10.1007/s11239-020-02072-0.
2
The efficacy of hyperbaric oxygen therapy in the treatment of central retinal artery occlusion.高压氧疗法治疗视网膜中央动脉阻塞的疗效
BMJ Case Rep. 2017 May 12;2017:bcr-2017-220113. doi: 10.1136/bcr-2017-220113.
3
Hyperbaric oxygen treatment of nonacute central retinal artery occlusion.高压氧治疗非急性视网膜中央动脉阻塞
Undersea Hyperb Med. 2009 Nov-Dec;36(6):401-5.
4
A comprehensive evaluation of efficacy of hyperbaric oxygen therapy in non-arteritic central retinal artery occlusion using enhanced depth imaging optical coherence tomography.应用增强深度成像光学相干断层扫描技术对高压氧治疗非动脉炎性中央视网膜动脉阻塞的疗效进行全面评估。
Sci Rep. 2024 Oct 10;14(1):23676. doi: 10.1038/s41598-024-71895-1.
5
Efficacy and safety of hyperbaric oxygen therapy monitored by fluorescein angiography in patients with retinal artery occlusion.荧光素眼底血管造影监测高压氧治疗视网膜动脉阻塞的疗效及安全性。
Br J Ophthalmol. 2024 Jun 20;108(7):956-962. doi: 10.1136/bjo-2023-323972.
6
Development of visual acuity under hyperbaric oxygen treatment (HBO) in non arteritic retinal branch artery occlusion.高压氧治疗(HBO)对非动脉炎性视网膜分支动脉阻塞患者视力的影响。
Graefes Arch Clin Exp Ophthalmol. 2020 Feb;258(2):303-310. doi: 10.1007/s00417-019-04568-9. Epub 2019 Dec 20.
7
Efficacy and safety of intra-arterial thrombolysis in central retinal artery occlusion.眼动脉阻塞患者行眼动脉内溶栓治疗的效果及安全性评估。
Invest Ophthalmol Vis Sci. 2013 Nov 21;54(12):7746-55. doi: 10.1167/iovs.13-12952.
8
[Treatment of Acute Central Retinal Artery Occlusion (CRAO) by Hyperbaric Oxygenation Therapy (HBO)--Pilot study with 21 patients].[高压氧疗法(HBO)治疗急性视网膜中央动脉阻塞(CRAO)——21例患者的初步研究]
Klin Monbl Augenheilkd. 2002 Oct;219(10):728-34. doi: 10.1055/s-2002-35687.
9
Hyperbaric oxygen therapy in combination with systemic treatment of sickle cell disease presenting as central retinal artery occlusion: a case report.高压氧治疗联合系统性治疗镰状细胞病所致视网膜中央动脉阻塞:一例报告
J Med Case Rep. 2014 Nov 17;8:370. doi: 10.1186/1752-1947-8-370.
10
Hyperbaric oxygen for the treatment of the rare combination of central retinal vein occlusion and cilioretinal artery occlusion.高压氧治疗视网膜中央静脉阻塞合并睫状视网膜动脉阻塞的罕见组合
Diving Hyperb Med. 2016 Mar;46(1):50-3.

引用本文的文献

1
Retinal ischemia due to different stages of atherosclerosis - insights from a retrospective study on central retinal artery occlusion.不同阶段动脉粥样硬化所致视网膜缺血——来自视网膜中央动脉阻塞回顾性研究的见解
Neurol Res Pract. 2025 Jul 22;7(1):50. doi: 10.1186/s42466-025-00413-z.
2
Complete Vision Recovery After Filler-Induced Blindness Using Hyperbaric Oxygen Therapy: Case Report and Literature Review.高压氧治疗填充剂致盲后视力完全恢复:病例报告与文献综述
Aesthet Surg J Open Forum. 2024 May 15;6:ojae036. doi: 10.1093/asjof/ojae036. eCollection 2024.
3
[Perioperative visual loss : Rare, unknown, relevant?].
[围手术期视力丧失:罕见、不明、相关?]
Anaesthesiologie. 2024 Apr;73(4):279-290. doi: 10.1007/s00101-024-01398-1.
4
Perioperative Care of the Patient with Eye Pathologies Undergoing Nonocular Surgery.眼部病变患者行非眼部手术的围手术期护理。
Anesthesiology. 2022 Nov 1;137(5):620-643. doi: 10.1097/ALN.0000000000004338.
5
Hyperbaric Oxygen Therapy for Central Retinal Artery Occlusion: Patient Selection and Perspectives.高压氧治疗视网膜中央动脉阻塞:患者选择与展望。
Clin Ophthalmol. 2021 Aug 13;15:3443-3457. doi: 10.2147/OPTH.S224192. eCollection 2021.